Proprietary modulated dielectric barrier discharge cold-plasma technology for continuous air and surface microbial treatment. Requires no added chemical treatment products and is engineered for occupied facilities when used per approved configuration and manufacturer instructions.
*Performance claims are based on third-party laboratory testing against specific organisms in a 2,640 ft³ chamber under defined conditions. Real-world results vary with existing bioburden and facility conditions. **PathogenFocus does not make health claims. ***The PathogenFocus MDBD cold-plasma air treatment system is not intended for use on medical devices.
© 2026 PathogenFocus. All rights reserved.
ADB technology in use across 1,000+ installations since 2008.